PMID: 15331539Aug 28, 2004Paper

Peptides from common viral and bacterial pathogens can efficiently activate diabetogenic T-cells

Diabetes
Valeria A JudkowskiClemencia Pinilla

Abstract

Cross-reactivity between an autoantigen and unknown microbial epitopes has been proposed as a molecular mechanism involved in the development of insulin-dependent diabetes (type 1 diabetes). Type 1 diabetes is an autoimmune disease that occurs in humans and the nonobese diabetic (NOD) mouse. BDC2.5 is an islet-specific CD4+ T-cell clone derived from the NOD mouse whose natural target antigen is unknown. A biometrical analysis of screening data from BDC2.5 T-cells and a positional scanning synthetic combinatorial library (PS-SCL) was used to analyze and rank all peptides in public viral and bacterial protein databases and identify potential molecular mimic sequences with predicted reactivity. Selected sequences were synthesized and tested for stimulatory activity with BDC2.5 T-cells. Active peptides were identified, and some of them were also able to stimulate spontaneously activated T-cells derived from young, pre-diabetic NOD mice, indicating that the reactivity of the BDC2.5 T-cell is directed at numerous mouse peptides. Our results provide evidence for their possible role as T-cell ligands involved in the activation of diabetogenic T-cells.

References

Nov 1, 1990·The Journal of Experimental Medicine·G BenichouE E Sercarz
Dec 1, 1990·Immunological Reviews·D E SmilekH O McDevitt
Jan 1, 1990·Annual Review of Immunology·L Castaño, G S Eisenbarth
Oct 1, 1988·Diabetes·K HaskinsK Lafferty
Jan 1, 1989·Annual Review of Immunology·V KumarL Hood
May 1, 1995·Nature Medicine·H BaumM Peakman
Apr 1, 1993·Trends in Biochemical Sciences·H BaumA K Burroughs
Oct 8, 1998·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M B Oldstone
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·B AndersonP Santamaria
Aug 24, 1999·European Journal of Immunology·H S HiemstraJ W Drijfhout
Dec 2, 1999·Nature·A W Goldrath, M J Bevan
Jan 13, 2001·Current Opinion in Immunology·C Watts
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·H S HiemstraB O Roep
Apr 4, 2001·The Journal of Clinical Investigation·G Sønderstrup, H O McDevitt
Jun 11, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Osami KanagawaBarbala A Vaupel
Jul 24, 2002·Journal of Immunological Methods·Eva BorràsClemencia Pinilla
Nov 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Verena Rubio-GodoyDanila Valmori
Jan 9, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yasushi UemuraYasuharu Nishimura
Mar 23, 2004·Annals of the New York Academy of Sciences·Gerry Melino

❮ Previous
Next ❯

Citations

Apr 29, 2005·Diabetes/metabolism Research and Reviews
May 9, 2006·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Junbao YangWilliam W Kwok
Feb 10, 2007·Molecular Immunology·Deepak YadavNora Sarvetnick
Nov 7, 2012·Current Protocols in Immunology·Clemencia PinillaRichard A Houghten

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.